While the FDA has approved Wegovy for weight loss, there is another version of semaglutide prescribed under the brand name Ozempic which is FDA-approved for type 2 diabetes
Their mechanisms and evidence bases are distinct
A generic could lower prices significantly, enabling access to millions of new patients
Large employers can pay extra to maintain coverage
d) Normal or clinically insignificant biochemical, hematological, urine and serology parameters
Food and Drug Administration (FDA) include: semaglutide (Ozempic, Wegovy, Rybelsus) tirzepatide (Mounjaro, Zepbound) liraglutide (Victoza, Saxenda) dulaglutide (Trulicity) exenatide (Byetta, Bydureon) lixisenatide (Adlyxin) Each works a bit differently and is FDA-approved for different uses